<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Fri, 28 Aug 2026 17:02:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Form  SCHEDULE 13G/A  JUPITER NEUROSCIENCES,                 Filed by: Orca Capital AG</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++JUPITER+NEUROSCIENCES%2C+++++++++++++++++Filed+by%3A+Orca+Capital+AG/26998917.html</link>
   <description>si-local-file:///var/storage/secattach/20260828/26998917.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++JUPITER+NEUROSCIENCES%2C+++++++++++++++++Filed+by%3A+Orca+Capital+AG/26998917.html</guid>
   <pubDate>Fri, 28 Aug 2026 17:02:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">JUNS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52729045</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13G/A  JUPITER NEUROSCIENCES,                 Filed by: Orca Capital AG</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++JUPITER+NEUROSCIENCES%2C+++++++++++++++++Filed+by%3A+Orca+Capital+AG/26998917.html</link>
   <description>si-local-file:///var/storage/secattach/20260828/26998917.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++JUPITER+NEUROSCIENCES%2C+++++++++++++++++Filed+by%3A+Orca+Capital+AG/26998917.html</guid>
   <pubDate>Fri, 28 Aug 2026 17:02:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">JUNS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52729045</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13G  JUPITER NEUROSCIENCES,                 Filed by: Orca Capital AG</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++JUPITER+NEUROSCIENCES%2C+++++++++++++++++Filed+by%3A+Orca+Capital+AG/26998875.html</link>
   <description>si-local-file:///var/storage/secattach/20260828/26998875.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++JUPITER+NEUROSCIENCES%2C+++++++++++++++++Filed+by%3A+Orca+Capital+AG/26998875.html</guid>
   <pubDate>Fri, 28 Aug 2026 17:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">JUNS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52729045</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13G  JUPITER NEUROSCIENCES,                 Filed by: Orca Capital AG</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++JUPITER+NEUROSCIENCES%2C+++++++++++++++++Filed+by%3A+Orca+Capital+AG/26998875.html</link>
   <description>si-local-file:///var/storage/secattach/20260828/26998875.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++JUPITER+NEUROSCIENCES%2C+++++++++++++++++Filed+by%3A+Orca+Capital+AG/26998875.html</guid>
   <pubDate>Fri, 28 Aug 2026 17:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">JUNS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52729045</category>
   	  </item>
  <item>
   <title>Form  8-K        JUPITER NEUROSCIENCES,    For: Aug 27</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++JUPITER+NEUROSCIENCES%2C++++For%3A+Aug+27/26997845.html</link>
   <description>si-local-file:///var/storage/secattach/20260828/26997845.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++JUPITER+NEUROSCIENCES%2C++++For%3A+Aug+27/26997845.html</guid>
   <pubDate>Fri, 28 Aug 2026 16:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">JUNS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52729045</category>
   	  </item>
  <item>
   <title>Form  8-K        JUPITER NEUROSCIENCES,    For: Aug 27</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++JUPITER+NEUROSCIENCES%2C++++For%3A+Aug+27/26997845.html</link>
   <description>si-local-file:///var/storage/secattach/20260828/26997845.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++JUPITER+NEUROSCIENCES%2C++++For%3A+Aug+27/26997845.html</guid>
   <pubDate>Fri, 28 Aug 2026 16:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">JUNS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52729045</category>
   	  </item>
  <item>
   <title>Form  8-K        JUPITER NEUROSCIENCES,    For: Aug 26</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++JUPITER+NEUROSCIENCES%2C++++For%3A+Aug+26/26984317.html</link>
   <description>si-local-file:///var/storage/secattach/20260827/26984317.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++JUPITER+NEUROSCIENCES%2C++++For%3A+Aug+26/26984317.html</guid>
   <pubDate>Thu, 27 Aug 2026 06:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">JUNS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52729045</category>
   	  </item>
  <item>
   <title>Form  8-K        JUPITER NEUROSCIENCES,    For: Aug 26</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++JUPITER+NEUROSCIENCES%2C++++For%3A+Aug+26/26984317.html</link>
   <description>si-local-file:///var/storage/secattach/20260827/26984317.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++JUPITER+NEUROSCIENCES%2C++++For%3A+Aug+26/26984317.html</guid>
   <pubDate>Thu, 27 Aug 2026 06:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">JUNS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52729045</category>
   	  </item>
  <item>
   <title>Form  8-K        JUPITER NEUROSCIENCES,    For: Aug 24</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++JUPITER+NEUROSCIENCES%2C++++For%3A+Aug+24/26968894.html</link>
   <description>si-local-file:///var/storage/secattach/20260824/26968894.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++JUPITER+NEUROSCIENCES%2C++++For%3A+Aug+24/26968894.html</guid>
   <pubDate>Mon, 24 Aug 2026 16:53:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">JUNS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52729045</category>
   	  </item>
  <item>
   <title>Form  8-K        JUPITER NEUROSCIENCES,    For: Aug 24</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++JUPITER+NEUROSCIENCES%2C++++For%3A+Aug+24/26968894.html</link>
   <description>si-local-file:///var/storage/secattach/20260824/26968894.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++JUPITER+NEUROSCIENCES%2C++++For%3A+Aug+24/26968894.html</guid>
   <pubDate>Mon, 24 Aug 2026 16:53:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">JUNS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52729045</category>
   	  </item>
  <item>
   <title>Form  8-K        JUPITER NEUROSCIENCES,    For: Aug 21</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++JUPITER+NEUROSCIENCES%2C++++For%3A+Aug+21/26964497.html</link>
   <description>si-local-file:///var/storage/secattach/20260824/26964497.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++JUPITER+NEUROSCIENCES%2C++++For%3A+Aug+21/26964497.html</guid>
   <pubDate>Mon, 24 Aug 2026 08:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">JUNS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52729045</category>
   	  </item>
  <item>
   <title>Form  8-K        JUPITER NEUROSCIENCES,    For: Aug 21</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++JUPITER+NEUROSCIENCES%2C++++For%3A+Aug+21/26964497.html</link>
   <description>si-local-file:///var/storage/secattach/20260824/26964497.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++JUPITER+NEUROSCIENCES%2C++++For%3A+Aug+21/26964497.html</guid>
   <pubDate>Mon, 24 Aug 2026 08:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">JUNS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52729045</category>
   	  </item>
  <item>
   <title>Form  424B5      JUPITER NEUROSCIENCES,               </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++424B5++++++JUPITER+NEUROSCIENCES%2C+++++++++++++++/26964439.html</link>
   <description>si-local-file:///var/storage/secattach/20260824/26964439.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++424B5++++++JUPITER+NEUROSCIENCES%2C+++++++++++++++/26964439.html</guid>
   <pubDate>Mon, 24 Aug 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">JUNS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52729045</category>
   	  </item>
  <item>
   <title>Form  424B5      JUPITER NEUROSCIENCES,               </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++424B5++++++JUPITER+NEUROSCIENCES%2C+++++++++++++++/26964439.html</link>
   <description>si-local-file:///var/storage/secattach/20260824/26964439.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++424B5++++++JUPITER+NEUROSCIENCES%2C+++++++++++++++/26964439.html</guid>
   <pubDate>Mon, 24 Aug 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">JUNS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52729045</category>
   	  </item>
  <item>
   <title>Jupiter Neurosciences prices $2M registered direct offering of shares</title>
   <link>http://www.streetinsider.com/Equity+Offerings/Jupiter+Neurosciences+prices+%242M+registered+direct+offering+of+shares/26960178.html</link>
   <description>

&lt;p&gt;Jupiter Neurosciences, Inc. (NASDAQ: JUNS) announced it has entered into a securities purchase agreement for a registered direct offering of 307,692 shares of common stock, with gross proceeds of approximately $2.0 million, according to a company press release.&lt;/p&gt;

&lt;p&gt;D. Boral Capital LLC is acting as the exclusive placement agent for the offering. The closing is expected to occur on or about August 24, 2026, subject to customary closing conditions.&lt;/p&gt;

&lt;p&gt;The shares are being offered pursuant to an effective shelf registration statement on Form S-3 (Registration No. 333-295085), which was declared effective by the U.S. Securities and Exchange Commission on April 24, 2026.&lt;/p&gt;

&lt;p&gt;Jupiter</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Equity+Offerings/Jupiter+Neurosciences+prices+%242M+registered+direct+offering+of+shares/26960178.html</guid>
   <pubDate>Fri, 21 Aug 2026 12:20:08 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">JUNS</category>
   	  </item>
  <item>
   <title>Jupiter Neurosciences Announces Pricing of $2.0 Million Registered Direct Offering</title>
   <link>http://www.streetinsider.com/Press+Releases/Jupiter+Neurosciences+Announces+Pricing+of+%242.0+Million+Registered+Direct+Offering/26960176.html</link>
   <description>&lt;p align=&quot;justify&quot;&gt;&lt;b&gt;New York, Aug.  21, 2026  (GLOBE NEWSWIRE) -- &lt;/b&gt;Jupiter Neurosciences, Inc. (NASDAQ: JUNS) (&quot;Jupiter&quot; or the &quot;Company&quot;), a clinical-stage biopharmaceutical company focused on central nervous system disorders and neuroinflammation, today announced it has entered into a securities purchase agreement for the purchase and sale of 307,692 shares of common stock in a registered direct offering.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The gross proceeds of the offering are approximately $2.0 million (the &quot;Offering&quot;).&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;D. Boral Capital LLC is acting as the exclusive placement agent for the Offering.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The closing of the Offering is expected to occur on</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Jupiter+Neurosciences+Announces+Pricing+of+%242.0+Million+Registered+Direct+Offering/26960176.html</guid>
   <pubDate>Fri, 21 Aug 2026 12:20:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">JUNS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JUNS</category>
   	  </item>
  <item>
   <title>Jupiter Neurosciences Announces Pricing of $2.0 Million Registered Direct Offering</title>
   <link>http://www.streetinsider.com/Press+Releases/Jupiter+Neurosciences+Announces+Pricing+of+%242.0+Million+Registered+Direct+Offering/26960176.html</link>
   <description>&lt;p align=&quot;justify&quot;&gt;&lt;b&gt;New York, Aug.  21, 2026  (GLOBE NEWSWIRE) -- &lt;/b&gt;Jupiter Neurosciences, Inc. (NASDAQ: JUNS) (&quot;Jupiter&quot; or the &quot;Company&quot;), a clinical-stage biopharmaceutical company focused on central nervous system disorders and neuroinflammation, today announced it has entered into a securities purchase agreement for the purchase and sale of 307,692 shares of common stock in a registered direct offering.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The gross proceeds of the offering are approximately $2.0 million (the &quot;Offering&quot;).&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;D. Boral Capital LLC is acting as the exclusive placement agent for the Offering.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The closing of the Offering is expected to occur on</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Jupiter+Neurosciences+Announces+Pricing+of+%242.0+Million+Registered+Direct+Offering/26960176.html</guid>
   <pubDate>Fri, 21 Aug 2026 12:20:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">JUNS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JUNS</category>
   	  </item>
  <item>
   <title>Jupiter Neurosciences Announces Pricing of $2.0 Million Registered Direct Offering</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Jupiter+Neurosciences+Announces+Pricing+of+%242.0+Million+Registered+Direct+Offering/26960176.html</link>
   <description>&lt;p align=&quot;justify&quot;&gt;&lt;b&gt;New York, Aug.  21, 2026  (GLOBE NEWSWIRE) -- &lt;/b&gt;Jupiter Neurosciences, Inc. (NASDAQ: JUNS) (&quot;Jupiter&quot; or the &quot;Company&quot;), a clinical-stage biopharmaceutical company focused on central nervous system disorders and neuroinflammation, today announced it has entered into a securities purchase agreement for the purchase and sale of 307,692 shares of common stock in a registered direct offering.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The gross proceeds of the offering are approximately $2.0 million (the &quot;Offering&quot;).&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;D. Boral Capital LLC is acting as the exclusive placement agent for the Offering.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The closing of the Offering is expected to occur on</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Jupiter+Neurosciences+Announces+Pricing+of+%242.0+Million+Registered+Direct+Offering/26960176.html</guid>
   <pubDate>Fri, 21 Aug 2026 12:20:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">JUNS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JUNS</category>
   	  </item>
  <item>
   <title>Jupiter Neurosciences Announces Pricing of $2.0 Million Registered Direct Offering</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Jupiter+Neurosciences+Announces+Pricing+of+%242.0+Million+Registered+Direct+Offering/26960176.html</link>
   <description>&lt;p align=&quot;justify&quot;&gt;&lt;b&gt;New York, Aug.  21, 2026  (GLOBE NEWSWIRE) -- &lt;/b&gt;Jupiter Neurosciences, Inc. (NASDAQ: JUNS) (&quot;Jupiter&quot; or the &quot;Company&quot;), a clinical-stage biopharmaceutical company focused on central nervous system disorders and neuroinflammation, today announced it has entered into a securities purchase agreement for the purchase and sale of 307,692 shares of common stock in a registered direct offering.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The gross proceeds of the offering are approximately $2.0 million (the &quot;Offering&quot;).&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;D. Boral Capital LLC is acting as the exclusive placement agent for the Offering.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The closing of the Offering is expected to occur on</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Jupiter+Neurosciences+Announces+Pricing+of+%242.0+Million+Registered+Direct+Offering/26960176.html</guid>
   <pubDate>Fri, 21 Aug 2026 12:20:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">JUNS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JUNS</category>
   	  </item>
  <item>
   <title>PharmAla Biotech Provides Corporate Update: U.S. Patent Granted Covering Novel Enantioselective Processes, Decision on APA-01, and Engagement of Canaccord Genuity as Exclusive Investment Banking Partn</title>
   <link>http://www.streetinsider.com/Press+Releases/PharmAla+Biotech+Provides+Corporate+Update%3A+U.S.+Patent+Granted+Covering+Novel+Enantioselective+Processes%2C+Decision+on+APA-01%2C+and+Engagement+of+Canaccord+Genuity+as+Exclusive+Investment+Banking+Partn/26958375.html</link>
   <description>&lt;ul type=&quot;disc&quot;&gt;&lt;li style=&quot;list-style-position:inside; text-align:center;&quot;&gt;&lt;strong&gt;U.S. Patent 12,679,817, covering novel processes for preparing the (R)- and (S)-enantiomers of MDMA and MBDB, granted to PharmAla by the US Patent and Trademark Office (USPTO)&lt;/strong&gt;&lt;/li&gt;&lt;li style=&quot;list-style-position:inside; text-align:center;&quot;&gt;&lt;strong&gt;&lt;em&gt;PharmAla has exercised its option to cancel the proposed licensing of APA-01 to Restora Neurosciences, and will evaluate in-house and co-development pathways&lt;/em&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li style=&quot;list-style-position:inside; text-align:center;&quot;&gt;&lt;strong&gt;&lt;em&gt;Canaccord Genuity LLC has been engaged as exclusive financial advisor and placement agent&lt;/em&gt;&lt;/strong&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p&gt;TORONTO, Aug.  21, 2026  (GLOBE NEWSWIRE) -- &lt;strong&gt;PharmAla Biotech Holdings Inc.&lt;/strong&gt; (“PharmAla” or the “Company”) (CSE: MDMA) (OTCQB: MDXXF), a biotechnology company focused on the research, development, and manufacturing of</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/PharmAla+Biotech+Provides+Corporate+Update%3A+U.S.+Patent+Granted+Covering+Novel+Enantioselective+Processes%2C+Decision+on+APA-01%2C+and+Engagement+of+Canaccord+Genuity+as+Exclusive+Investment+Banking+Partn/26958375.html</guid>
   <pubDate>Fri, 21 Aug 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">JUNS</category>
   	  </item>
  <item>
   <title>PharmAla Biotech Provides Corporate Update: U.S. Patent Granted Covering Novel Enantioselective Processes, Decision on APA-01, and Engagement of Canaccord Genuity as Exclusive Investment Banking Partn</title>
   <link>http://www.streetinsider.com/Globe+Newswire/PharmAla+Biotech+Provides+Corporate+Update%3A+U.S.+Patent+Granted+Covering+Novel+Enantioselective+Processes%2C+Decision+on+APA-01%2C+and+Engagement+of+Canaccord+Genuity+as+Exclusive+Investment+Banking+Partn/26958375.html</link>
   <description>&lt;ul type=&quot;disc&quot;&gt;&lt;li style=&quot;list-style-position:inside; text-align:center;&quot;&gt;&lt;strong&gt;U.S. Patent 12,679,817, covering novel processes for preparing the (R)- and (S)-enantiomers of MDMA and MBDB, granted to PharmAla by the US Patent and Trademark Office (USPTO)&lt;/strong&gt;&lt;/li&gt;&lt;li style=&quot;list-style-position:inside; text-align:center;&quot;&gt;&lt;strong&gt;&lt;em&gt;PharmAla has exercised its option to cancel the proposed licensing of APA-01 to Restora Neurosciences, and will evaluate in-house and co-development pathways&lt;/em&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li style=&quot;list-style-position:inside; text-align:center;&quot;&gt;&lt;strong&gt;&lt;em&gt;Canaccord Genuity LLC has been engaged as exclusive financial advisor and placement agent&lt;/em&gt;&lt;/strong&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p&gt;TORONTO, Aug.  21, 2026  (GLOBE NEWSWIRE) -- &lt;strong&gt;PharmAla Biotech Holdings Inc.&lt;/strong&gt; (“PharmAla” or the “Company”) (CSE: MDMA) (OTCQB: MDXXF), a biotechnology company focused on the research, development, and manufacturing of</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/PharmAla+Biotech+Provides+Corporate+Update%3A+U.S.+Patent+Granted+Covering+Novel+Enantioselective+Processes%2C+Decision+on+APA-01%2C+and+Engagement+of+Canaccord+Genuity+as+Exclusive+Investment+Banking+Partn/26958375.html</guid>
   <pubDate>Fri, 21 Aug 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">JUNS</category>
   	  </item>
  <item>
   <title>Form  10-Q       JUPITER NEUROSCIENCES,    For: Jun 30</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++JUPITER+NEUROSCIENCES%2C++++For%3A+Jun+30/26931965.html</link>
   <description>si-local-file:///var/storage/secattach/20260814/26931965.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++JUPITER+NEUROSCIENCES%2C++++For%3A+Jun+30/26931965.html</guid>
   <pubDate>Fri, 14 Aug 2026 16:43:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">JUNS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52729045</category>
   	  </item>
  <item>
   <title>Form  10-Q       JUPITER NEUROSCIENCES,    For: Jun 30</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++JUPITER+NEUROSCIENCES%2C++++For%3A+Jun+30/26931965.html</link>
   <description>si-local-file:///var/storage/secattach/20260814/26931965.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++JUPITER+NEUROSCIENCES%2C++++For%3A+Jun+30/26931965.html</guid>
   <pubDate>Fri, 14 Aug 2026 16:43:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">JUNS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52729045</category>
   	  </item>
  <item>
   <title>Form  8-K        JUPITER NEUROSCIENCES,    For: Aug 06</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++JUPITER+NEUROSCIENCES%2C++++For%3A+Aug+06/26880177.html</link>
   <description>si-local-file:///var/storage/secattach/20260806/26880177.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++JUPITER+NEUROSCIENCES%2C++++For%3A+Aug+06/26880177.html</guid>
   <pubDate>Thu, 06 Aug 2026 08:56:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">JUNS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52729045</category>
   	  </item>
  <item>
   <title>Form  8-K        JUPITER NEUROSCIENCES,    For: Aug 06</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++JUPITER+NEUROSCIENCES%2C++++For%3A+Aug+06/26880177.html</link>
   <description>si-local-file:///var/storage/secattach/20260806/26880177.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++JUPITER+NEUROSCIENCES%2C++++For%3A+Aug+06/26880177.html</guid>
   <pubDate>Thu, 06 Aug 2026 08:56:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">JUNS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52729045</category>
   	  </item>
 </channel>
</rss>
